140 related articles for article (PubMed ID: 32491279)
1. Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancer.
Salomonsson A; Micke P; Mattsson JSM; La Fleur L; Isaksson J; Jönsson M; Nodin B; Botling J; Uhlén M; Jirström K; Staaf J; Planck M; Brunnström H
Cancer Med; 2020 Aug; 9(15):5609-5619. PubMed ID: 32491279
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical significance of RBM3 immunostaining in non-small cell lung cancers.
Melling N; Bachmann K; Hofmann B; El Gammal AT; Reeh M; Mann O; Moebius C; Blessmann M; Izbicki JR; Grupp K
J Cancer Res Clin Oncol; 2019 Apr; 145(4):873-879. PubMed ID: 30758670
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.
Boman K; Segersten U; Ahlgren G; Eberhard J; Uhlén M; Jirström K; Malmström PU
BMC Urol; 2013 Apr; 13():17. PubMed ID: 23565664
[TBL] [Abstract][Full Text] [Related]
4. High RNA-Binding Motif Protein 3 (RBM3) Expression is Independently Associated with Prolonged Overall Survival in Intestinal-Type Gastric Cancer.
Ye F; Jin P; Cai X; Cai P; Cai H
Med Sci Monit; 2017 Dec; 23():6033-6041. PubMed ID: 29263314
[TBL] [Abstract][Full Text] [Related]
5. High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma.
Nodin B; Fridberg M; Jonsson L; Bergman J; Uhlén M; Jirström K
Diagn Pathol; 2012 Jul; 7():82. PubMed ID: 22805320
[TBL] [Abstract][Full Text] [Related]
6. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study.
Jonsson L; Bergman J; Nodin B; Manjer J; Pontén F; Uhlén M; Jirström K
J Transl Med; 2011 Jul; 9():114. PubMed ID: 21777469
[TBL] [Abstract][Full Text] [Related]
7. Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer.
Olofsson SE; Nodin B; Gaber A; Eberhard J; Uhlén M; Jirström K; Jerkeman M
PLoS One; 2015; 10(3):e0121300. PubMed ID: 25811459
[TBL] [Abstract][Full Text] [Related]
8. Loss of RNA-binding motif protein 3 expression is associated with right-sided localization and poor prognosis in colorectal cancer.
Melling N; Simon R; Mirlacher M; Izbicki JR; Stahl P; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
Histopathology; 2016 Jan; 68(2):191-8. PubMed ID: 25922889
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of RBM3 expression in surgically treated colorectal lung metastases and paired primary tumors.
Vidarsdottir H; Siesing C; Nodin B; Jönsson P; Eberhard J; Jirström K; Brunnström H
J Surg Oncol; 2021 Mar; 123(4):1144-1156. PubMed ID: 33497473
[TBL] [Abstract][Full Text] [Related]
10. High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.
Siesing C; Sorbye H; Dragomir A; Pfeiffer P; Qvortrup C; Pontén F; Jirström K; Glimelius B; Eberhard J
PLoS One; 2017; 12(8):e0182512. PubMed ID: 28800641
[TBL] [Abstract][Full Text] [Related]
11. The prognostic and clinicopathological significance of RBM3 in the survival of patients with tumor: A Prisma-compliant meta-analysis.
Gao G; Shi X; Long Y; Yao Z; Shen J; Shen L
Medicine (Baltimore); 2020 May; 99(19):e20002. PubMed ID: 32384455
[TBL] [Abstract][Full Text] [Related]
12. High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer.
Hjelm B; Brennan DJ; Zendehrokh N; Eberhard J; Nodin B; Gaber A; Pontén F; Johannesson H; Smaragdi K; Frantz C; Hober S; Johnson LB; Påhlman S; Jirström K; Uhlen M
Proteomics Clin Appl; 2011 Dec; 5(11-12):624-35. PubMed ID: 21956899
[TBL] [Abstract][Full Text] [Related]
13. High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions.
Grupp K; Wilking J; Prien K; Hube-Magg C; Sirma H; Simon R; Steurer S; Budäus L; Haese A; Izbicki J; Sauter G; Minner S; Schlomm T; Tsourlakis MC
Eur J Cancer; 2014 Mar; 50(4):852-61. PubMed ID: 24380696
[TBL] [Abstract][Full Text] [Related]
14. High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death.
Jonsson L; Hedner C; Gaber A; Korkocic D; Nodin B; Uhlén M; Eberhard J; Jirström K
Biomark Res; 2014; 2():11. PubMed ID: 24963396
[TBL] [Abstract][Full Text] [Related]
15. Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.
Boman K; Andersson G; Wennersten C; Nodin B; Ahlgren G; Jirström K
Biomark Res; 2017; 5():10. PubMed ID: 28293425
[TBL] [Abstract][Full Text] [Related]
16. Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome.
Grupp K; Hofmann B; Kutup A; Bachmann K; Bogoevski D; Melling N; Uzunoglu FG; El Gammal AT; Koop C; Simon R; Steurer S; Krech T; Burdak-Rothkamm S; Jacobsen F; Sauter G; Izbicki J; Wilczak W
BMC Cancer; 2018 Nov; 18(1):1106. PubMed ID: 30419865
[TBL] [Abstract][Full Text] [Related]
17. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
Micke P; Mattsson JS; Edlund K; Lohr M; Jirström K; Berglund A; Botling J; Rahnenfuehrer J; Marincevic M; Pontén F; Ekman S; Hengstler J; Wöll S; Sahin U; Türeci O
Int J Cancer; 2014 Nov; 135(9):2206-14. PubMed ID: 24710653
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of p53 protein and p21(WAF1) in non-small-cell lung carcinoma].
Zhang H; Lü F; Yue W; Yan H; Deng L; Wang S
Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):328-30. PubMed ID: 11866928
[TBL] [Abstract][Full Text] [Related]
19. Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.
Yanagawa N; Leduc C; Kohler D; Saieg MA; John T; Sykes J; Yoshimoto M; Pintilie M; Squire J; Shepherd FA; Tsao MS
J Thorac Oncol; 2012 Oct; 7(10):1513-21. PubMed ID: 22982652
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of nuclear or cytoplasmic nucleolin expression in human non-small cell lung cancer and its relationship with DNA-PKcs.
Xu JY; Lu S; Xu XY; Hu SL; Li B; Li WX; Chang JY
Tumour Biol; 2016 Aug; 37(8):10349-56. PubMed ID: 26846099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
